PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer

PURPOSE: We investigated whether mutations in the gene encoding the phosphatidylinositol 3-kinase (PI3K) catalytic subunit (PIK3CA) correlates with response to neoadjuvant human epidermal growth factor receptor 2 (HER2) –targeted therapies in patients with breast cancer. PATIENTS AND METHODS: Baseli...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Majewski, Ian J., Nuciforo, Paolo, Mittempergher, Lorenza, Bosma, Astrid J., Eidtmann, Holger, Holmes, Eileen, Sotiriou, Christos, Fumagalli, Debora, Jimenez, Jose, Aura, Claudia, Prudkin, Ludmila, Díaz-Delgado, Maria Carmen, de la Peña, Lorena, Loi, Sherene, Ellis, Catherine, Schultz, Nikolaus, de Azambuja, Evandro, Harbeck, Nadia, Piccart-Gebhart, Martine, Bernards, René, Baselga, José
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2015
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087318/
https://ncbi.nlm.nih.gov/pubmed/25559818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.2158
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker